ACHV News and Press, Achieve Life Sciences Inc. From 07/18/23

SEATTLE and VANCOUVER, British Columbia, July 18, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced part...

Cytisinicline 6- and 12-week dosing schedules, with behavioral support, demonstrated “smoking cessation efficacy and excellent tolerability” Supports potential for cytisinicline to be the first pharmacotherapy approved for smoking cessation in nearly two decades SEAT...

SEATTLE and VANCOUVER, British Columbia, June 06, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that...

2023-05-28 04:39:42 ET Summary Efficacy: Phase 3 ORCA-3 trial showed significant efficacy of cytisinicline in smoking cessation, reinforcing data from ORCA-2. Safety: Cytisinicline exhibited no serious treatment-related adverse events, implying safe long-term usage. Financials...

2023-05-25 09:23:57 ET Achieve Life Sciences ( NASDAQ: ACHV ) shares are down 2.24% premarket on Thursday after the firm has entered into a securities purchase pact with certain institutional investors providing for the purchase and sale of 3M shares of common stock at a price...

SEATTLE and VANCOUVER, British Columbia, May 25, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking cessation and nicotine dependence, today announced that ...

2023-05-23 10:08:04 ET Gainers: CohBar ( CWBR ) +157% . Ocean Biomedical ( OCEA ) +79% . Shuttle Pharmaceuticals ( SHPH ) +46% . Icosavax ( ICVX ) +31% . Recursion Pharmaceuticals ( RXRX ) +20% . Losers: NantHealth ( ...

2023-05-23 07:05:48 ET Achieve Life Sciences ( NASDAQ: ACHV ) said cytisinicline showed a statistically significant benefit in helping people quit smoking compared to placebo, with low rates of adverse events in a second, confirmatory phase 3 trial. The study, dubbed&#...

ORCA-3 demonstrated statistically significant topline results in primary and secondary smoking cessation endpoints for both 6- and 12-week cytisinicline treatment durations compared to placebo Cytisinicline demonstrated 6x increase in odds of continuous smoking abstinence at 6 months ...

2023-05-17 10:16:29 ET Pharmaceutical company Achieve Life Sciences ( NASDAQ: ACHV ) said on Wednesday that it has refinanced an outstanding loan. The loan is a the part of a previous debt agreement with Silicon Valley Bank, a division of First-Citizens Bank. The new ...